Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017618

« Back to Dashboard

NDA 017618 describes BRICANYL, which is a drug marketed by Sanofi Aventis Us and is included in three NDAs. Additional details are available on the BRICANYL profile page.

The generic ingredient in BRICANYL is terbutaline sulfate. There are seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.

Summary for 017618

Tradename:	BRICANYL
Applicant:	Sanofi Aventis Us
Ingredient:	terbutaline sulfate
Patents:	0
Therapeutic Class:	Respiratory Tract Agents
Formulation / Manufacturing:	see details

Medical Subject Heading (MeSH) Categories for 017618

Adrenergic beta-2 Receptor Agonists
Bronchodilator Agents
Sympathomimetics
Tocolytic Agents

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	2.5MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:		RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	5MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:		RLD:	No

Expired US Patents for NDA 017618

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sanofi Aventis Us	BRICANYL	terbutaline sulfate	TABLET;ORAL	017618-002	Approved Prior to Jan 1, 1982	➤ Try a Free Trial	➤ Try a Free Trial
Sanofi Aventis Us	BRICANYL	terbutaline sulfate	TABLET;ORAL	017618-002	Approved Prior to Jan 1, 1982	➤ Try a Free Trial	➤ Try a Free Trial
Sanofi Aventis Us	BRICANYL	terbutaline sulfate	TABLET;ORAL	017618-001	Approved Prior to Jan 1, 1982	➤ Try a Free Trial	➤ Try a Free Trial
Sanofi Aventis Us	BRICANYL	terbutaline sulfate	TABLET;ORAL	017618-001	Approved Prior to Jan 1, 1982	➤ Try a Free Trial	➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.